Rotating injection sites and maintaining proper injection depth will prevent most localized reactions
Since then, several human GLP-1 RAs, such as liraglutide, dulaglutide, semaglutide, and tirzepatide, have been developed, offering enhanced pharmacokinetic properties for more convenient administration [1]
Pregnant and breastfeeding individuals should not use tirzepatide because reproductive safety data in humans remains limited
Non-response might indicate product quality issues, dosing inadequacy, injury severity beyond peptide help, or individual variation in response
The first step you need to do and one you don't have to do in person is find a telemedicine provider you can trust
Should You Stay on GLP-1 Long-Term or Plan to Stop